Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥993m2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥2.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.2bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥69m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥94m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥88m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥333m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥120m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥112m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥119m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥76m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥243m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥82m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥76m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥82m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥4.5bnat 2023-09-30Cons.Assets
Total assets¥4.5bnat 2023-03-31Cons.Assets
Total assets¥4.4bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.1bnat 2023-09-30Cons.Liabilities
Total liabilities¥1.1bnat 2023-03-31Cons.Liabilities
Net assets / equity¥3.4bnat 2023-09-30Cons.Net assets
Net assets / equity¥3.4bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.3bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.0bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥1.9bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥2.0bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥174m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥105m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥191m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥40m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥24m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥19m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥140m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥226m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥130m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥55.772023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥63.632023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥177.532022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.112022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥73.992022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio76.2%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio75.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio74.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥332m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥332m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥9m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥345m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥345m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥103m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2023-04-01 → 2023-09-30¥317m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2023-04-01 → 2023-09-30¥317m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2023-04-01 → 2023-09-30¥110m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥993m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥993m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥222m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥48m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥103m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2022-04-01 → 2022-09-30¥84m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥234m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 430
ItemContextValueUnit
Retained earningsCurrentQuarterInstant1117012000JPY
Treasury stockPrior1YearInstant-166286000JPY
Treasury stockCurrentQuarterInstant-166397000JPY
Shareholders equityPrior1YearInstant3391374000JPY
Shareholders equityCurrentQuarterInstant3371785000JPY
Valuation difference on available for sale securitiesPrior1YearInstant14852000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant24183000JPY
Foreign currency translation adjustmentPrior1YearInstant11642000JPY
Foreign currency translation adjustmentCurrentQuarterInstant19416000JPY
Valuation and translation adjustmentsPrior1YearInstant26495000JPY
Valuation and translation adjustmentsCurrentQuarterInstant43599000JPY
Net assetsPrior1YearInstant3417869000JPY
Net assetsCurrentQuarterInstant3415385000JPY
Liabilities and net assetsPrior1YearInstant4519518000JPY
Liabilities and net assetsCurrentQuarterInstant4479220000JPY
Net salesPrior1YTDDuration1178700000JPY
Net salesCurrentYTDDuration993420000JPY
Cost of salesPrior1YTDDuration784662000JPY
Cost of salesCurrentYTDDuration604422000JPY
Gross profitPrior1YTDDuration394037000JPY
Gross profitCurrentYTDDuration388998000JPY
Selling general and administrative expensesPrior1YTDDuration300494000JPY
Selling general and administrative expensesCurrentYTDDuration319723000JPY
Operating incomePrior1YTDDuration93543000JPY
Operating incomeCurrentYTDDuration69275000JPY
Interest and dividends income noiPrior1YTDDuration2247000JPY
Interest and dividends income noiCurrentYTDDuration2843000JPY
Foreign exchange gains noiPrior1YTDDuration13771000JPY
Foreign exchange gains noiCurrentYTDDuration9453000JPY
Electricity sale income noiPrior1YTDDuration6677000JPY
Electricity sale income noiCurrentYTDDuration7005000JPY
Other noiPrior1YTDDuration7552000JPY
Other noiCurrentYTDDuration3061000JPY
Non operating incomePrior1YTDDuration30248000JPY
Non operating incomeCurrentYTDDuration22363000JPY
Interest expenses noePrior1YTDDuration195000JPY
Interest expenses noeCurrentYTDDuration133000JPY
Electricity sale expenses noePrior1YTDDuration3512000JPY
Electricity sale expenses noeCurrentYTDDuration3130000JPY
Non operating expensesPrior1YTDDuration3707000JPY
Non operating expensesCurrentYTDDuration3263000JPY
Ordinary incomePrior1YTDDuration120084000JPY
Ordinary incomeCurrentYTDDuration88375000JPY
Surrender value of insurance eiPrior1YTDDuration-JPY
Surrender value of insurance eiCurrentYTDDuration24026000JPY
Extraordinary incomePrior1YTDDuration-JPY
Extraordinary incomeCurrentYTDDuration24026000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration767000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration0JPY
Extraordinary lossPrior1YTDDuration767000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass